1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow 18F-FPPRGD2: new trials by email Literature Review of 18F-FPPRGD2 trials Research Report on 18F-FPPRGD2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation 18F-FPPRGD2, Positron emission tomography, Computed tomography - Aortic Aneurysm, Abdominal, Carotid Atherosclerosis | Phase 2 | Withdrawn | Stanford University | 2019-10-01 | 2021-05-21 | |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy 18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 / Phase 2 | Completed | Sanjiv Sam Gambhir | 25 | 2013-03-04 | 2019-10-03 |
Aortic Aneurysm, Abdominal (1) · Atherosclerosis (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carotid Artery Diseases (1) · Carotid Stenosis (1) · Colonic Neoplasms (1) · Esthesioneuroblastoma, Olfactory (1) · Glioblastoma (1) · Gliosarcoma (1) · Hypopharyngeal Neoplasms (1) · Inflammation (1)
Sanjiv Sam Gambhir (1) · Stanford University (1)
United States (2)
Michael V. McConnell, MD, MSEE (1) · Sanjiv Gambhir, MD, PhD (1)